A cautionary tale: How one biotech stock trader lost a small fortune, but emerged wiser - STAT
oo many of my Twitter interactions with biotech-loving retail investors are unpleasant. If I write an article raising doubts about a small drugmaker’s clinical trial results, or if I call out mis...
Read more